This Cancer Drug Candidate Could Be a Hit for Pfizer

This Cancer Drug Candidate Could Be a Hit for Pfizer

Submitted by admin on March 26, 2023 - 11:19pm
Source: 
Motley Fool
News Tags: 
Pfizer
elranatamab
Multiple Myeloma
Headline: 
This Cancer Drug Candidate Could Be a Hit for Pfizer
snippet: 
  • Elranatamab showed itself to be an effective therapy for multiple myeloma patients.
  • The drug candidate has great potential in a market estimated at some $20 billion.
  • Pfizer’s 4%-plus dividend yield could also be enticing to income investors.

Do Not Allow Advertisers to Use My Personal information